Physician

Yiming Wu, M.D, PH.D.

According to 2025 Medicare claims, Yiming Wu, M.D, PH.D. (NPI: 1225248669) practices cardiac electrophysiology in the Anchorage, AK market, with the plurality of this provider's patient population coming from Anchorage, AK. This provider's primary affiliated billing organization is ALASKA HEART INSTITUTE (NPI: 1992744114; TIN: 92-0165692) and primary practice location at 99508-4615. Wu is affiliated with the CHSPSC ACO 8, LLC (ACO ID: A3715) and Envoy Integrated Health ACO, LLC (ACO ID: A5392), participating under the MSSP model.

Wu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,206 traditional Medicare patients, billed 3,217 HCPCS/CPT codes, and received $383,536 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 836 prescription claims across 269 beneficiaries totaling $536,289 in drug costs, led by Eliquis (Apixaban). 2018 DME data shows 24 claims. Open Payments data shows 21 records totaling $1,735. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $131,232 to $536,289. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	787	2,117	$249,516
2016	678	2,226	$340,358
2017	688	2,213	$289,936
2018	1,193	3,127	$374,878
2019	813	2,532	$353,859
2020	815	2,094	$339,866
2021	859	2,307	$374,560
2022	801	2,436	$380,379
2023	1,033	2,597	$342,384
2024	1,206	3,217	$383,536

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	115	438	$131,232
2016	160	670	$216,058
2017	152	731	$248,167
2018	140	651	$259,942
2019	181	797	$389,123
2020	203	862	$476,001
2021	237	898	$532,487
2022	249	854	$540,478
2023	218	747	$531,895
2024	269	836	$536,289

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	24	$1,524
2017	N/R	N/R	N/R
2018	N/R	24	$1,247
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	236	236	$148
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	203	234	$113
93248	Heart rhythm review and interpretation of continous external ekg over 8-15 days	160	164	$25
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	653	808	$13
93246	Heart rhythm recording of continous external ekg over 8-15 days	152	158	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	242	19,141	$364,779
Multaq	Dronedarone Hcl	65	4,072	$103,000
Xarelto	Rivaroxaban	44	2,910	$51,837
Metoprolol Succinate	Metoprolol Succinate	150	11,741	$3,350
Amiodarone Hcl	Amiodarone Hcl	32	2,137	$1,029

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$1,735	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Yiming Wu, M.D, PH.D.?

Tedicare shows public-source Medicare data for Yiming Wu, M.D, PH.D. (NPI 1225248669), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yiming Wu, M.D, PH.D. have ACO affiliation data?

Yiming Wu, M.D, PH.D. is shown with ACO affiliation data for CHSPSC ACO 8, LLC (MSSP, ACO ID A3715) and Envoy Integrated Health ACO, LLC (MSSP, ACO ID A5392).

What billing organization is linked to Yiming Wu, M.D, PH.D.?

Yiming Wu, M.D, PH.D. is linked to ALASKA HEART INSTITUTE (billing NPI 1992744114) in the available physician profile data.

Does Yiming Wu, M.D, PH.D. have Open Payments data?

Yiming Wu, M.D, PH.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.